{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T01:34:07Z","timestamp":1789868047755,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"World Bank African Centers of Excellence grant","award":["ACE02-WACCBIP"],"award-info":[{"award-number":["ACE02-WACCBIP"]}]},{"name":"Wellcome Trust DELTAS grant","award":["107755\/Z\/15\/Z"],"award-info":[{"award-number":["107755\/Z\/15\/Z"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12936-017-1695-1","type":"journal-article","created":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T07:43:42Z","timestamp":1485157422000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine\u2013pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8512-8561","authenticated-orcid":false,"given":"Mamoudou","family":"Cisse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon A.","family":"Awandare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alamissa","family":"Soulama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halidou","family":"Tinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Hayette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Guiguemd\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,23]]},"reference":[{"key":"1695_CR1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4269\/ajtmh.2001.64.28","volume":"64","author":"RW Steketee","year":"2001","unstructured":"Steketee RW, Nahlen BL, Parise ME, Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg. 2001;64:28\u201335.","journal-title":"Am J Trop Med Hyg"},{"key":"1695_CR2","unstructured":"WHO. A strategic framework for malaria prevention and control during pregnancy in the African region. Brazzaville: World Health Organization, 2004. http\/\/ www.who.int\/malaria\/publications\/atoz\/afr_mal_04_01\/en . Accessed 19 May 2016."},{"key":"1695_CR3","unstructured":"WHO. Updated WHO Policy Recommendation (October 2012): Intermittent Preventative Treatment of Malaria in Pregnancy Using Sulfadoxine\u2013Pyrimethamine (IPTp-SP). Geneva: World Health Organization. http\/\/ www.who.int\/malaria\/iptp_sp_updated_policy_recommendation_en_102012.pdf . Accessed 19 May 2016."},{"key":"1695_CR4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/cid\/cir374","volume":"53","author":"OS Diakite","year":"2011","unstructured":"Diakite OS, Kayentao K, Traor\u00e9 BT, Djimde A, Traor\u00e9 B, Diallo M, et al. Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine\u2013pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial. Clin Infect Dis. 2011;53:215\u201323.","journal-title":"Clin Infect Dis"},{"key":"1695_CR5","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1086\/592455","volume":"198","author":"FP Mockenhaupt","year":"2008","unstructured":"Mockenhaupt FP, Bedu-Addo G, Eggelte TA, Hommerich L, Holmberg V, von Oertzen C, et al. Rapid increase in the prevalence of sulfadoxine\u2013pyrimethamine resistance among Plasmodium falciparum isolated from pregnant women in Ghana. J Infect Dis. 2008;198:1545\u20139.","journal-title":"J Infect Dis"},{"key":"1695_CR6","doi-asserted-by":"crossref","first-page":"9114","DOI":"10.1073\/pnas.85.23.9114","volume":"85","author":"D Peterson","year":"1988","unstructured":"Peterson D, Walliker D, Wellems T. Evidence that a point mutation in dihydrofolate reductase\u2013thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Natl Acad Sci USA. 1988;85:9114\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1695_CR7","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.94.25.13944","volume":"94","author":"T Triglia","year":"1997","unstructured":"Triglia T, Menting JG, Wilson C, Cowman AF. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc Natl Acad Sci USA. 1997;94:13944\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1695_CR8","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1128\/AAC.49.3.1101-1105.2005","volume":"49","author":"F Marks","year":"2005","unstructured":"Marks F, Evans J, Meyer CG, Browne EN, Flessner C, Von Kalckreuth V, et al. High prevalence of markers for sulfadoxine and pyrimethamine resistance in Plasmodium falciparum in the absence of drug pressure in the Ashanti Region of Ghana. Antimicrob Agents Chemother. 2005;49:1101\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"1695_CR9","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1159\/000430987","volume":"24","author":"BA Iwalokun","year":"2015","unstructured":"Iwalokun BA, Iwalokun SO, Adebodun V, Balogun M. Carriage of mutant dihydrofolate reductase and dihydropteroate synthase genes among Plasmodium falciparum isolates recovered from pregnant women with asymptomatic infection in Lagos, Nigeria. Med Princ Pract. 2015;24:436\u201343.","journal-title":"Med Princ Pract."},{"key":"1695_CR10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/cid\/ciq049","volume":"52","author":"C Men\u00e9ndez","year":"2011","unstructured":"Men\u00e9ndez C, Serra-Casas E, Scahill MD, Sanz S, Nhabomba A, Bardaj\u00ed A, et al. HIV and placental infection modulate the appearance of drug-resistant Plasmodium falciparum in pregnant women who receive intermittent preventive treatment. Clin Infect Dis. 2011;52:41\u20138.","journal-title":"Clin Infect Dis"},{"key":"1695_CR11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/cid\/cis301","volume":"55","author":"SM Taylor","year":"2012","unstructured":"Taylor SM, Antonia AL, Chaluluka E, Mwapasa V, Feng G, Molyneux ME, et al. Antenatal receipt of sulfadoxine\u2013pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study. Clin Infect Dis. 2012;55:42\u201350.","journal-title":"Clin Infect Dis"},{"key":"1695_CR12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12936-015-0676-5","volume":"14","author":"MNP Siame","year":"2015","unstructured":"Siame MNP, Mharakurwa S, Chipeta J, Thuma P, Michelo C. High prevalence of dhfr and dhps molecular markers in Plasmodium falciparum in pregnant women of Nchelenge district, Northern Zambia. Malar J. 2015;14:190.","journal-title":"Malar J."},{"key":"1695_CR13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4269\/ajtmh.2001.65.21","volume":"65","author":"FP Mockenhaupt","year":"2001","unstructured":"Mockenhaupt FP, Eggelte TA, Tamara B, Thompson WNA, Bienzle U. Plasmodium falciparum dihydrofolate reductase alleles and pyrimethamine use in pregnant ghanaian women. Am J Trop Med Hyg. 2001;65:21\u20136.","journal-title":"Am J Trop Med Hyg"},{"key":"1695_CR14","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1128\/AAC.00856-06","volume":"51","author":"FP Mockenhaupt","year":"2007","unstructured":"Mockenhaupt FP, Bedu-Addo G, Junge C, Hommerich L, Eggelte TA, Bienzle U. Markers of sulfadoxine\u2013pyrimethamine-resistant Plasmodium falciparum in placenta and circulation of pregnant women. Antimicrob Agents Chemother. 2007;51:332\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"1695_CR15","doi-asserted-by":"crossref","first-page":"9027","DOI":"10.1073\/pnas.0901415106","volume":"106","author":"WE Harrington","year":"2009","unstructured":"Harrington WE, Mutabingwa TK, Muehlenbachs A, Sorensen B, Bolla MC, Fried M, et al. Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women. Proc Natl Acad Sci USA. 2009;106:9027\u201332.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1695_CR16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/jac\/dkp467","volume":"65","author":"MK Bouyou-Akotet","year":"2010","unstructured":"Bouyou-Akotet MK, Mawili-Mboumba DP, Tchantchou TDD, Kombila M. High prevalence of sulfadoxine\/pyrimethamine-resistant alleles of Plasmodium falciparum isolates in pregnant women at the time of introduction of intermittent preventive treatment with sulfadoxine\/pyrimethamine in Gabon. J Antimicrob Chemother. 2010;65:438\u201341.","journal-title":"J Antimicrob Chemother"},{"key":"1695_CR17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1475-2875-13-41","volume":"13","author":"SO Coulibaly","year":"2014","unstructured":"Coulibaly SO, Kayentao K, Taylor S, Guirou EA, Khairallah C, Guindo N, et al. Parasite clearance following treatment with sulphadoxine\u2013pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study. Malar J. 2014;13:41.","journal-title":"Malar J."},{"key":"1695_CR18","doi-asserted-by":"crossref","first-page":"e0137440","DOI":"10.1371\/journal.pone.0137440","volume":"10","author":"MC Tahita","year":"2015","unstructured":"Tahita MC, Tinto H, Erhart A, Kazienga A, Fitzhenry R, VanOvermeir C, et al. Prevalence of the dhfr and dhps mutations among pregnant women in Rural Burkina Faso five years after the introduction of intermittent preventive treatment with sulfadoxine\u2013pyrimethamine. PLoS ONE. 2015;10:e0137440.","journal-title":"PLoS ONE"},{"key":"1695_CR19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1186\/s12879-014-0631-z","volume":"14","author":"M Cisse","year":"2014","unstructured":"Cisse M, Sangare I, Lougue G, Bamba S, Bayane D, Guiguemde RT. Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women attending antenatal clinic in Bobo-Dioulasso (Burkina Faso). BMC Infect Dis. 2014;14:631.","journal-title":"BMC Infect Dis"},{"key":"1695_CR20","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1017\/pao.2016.12","volume":"2","author":"M Cisse","year":"2016","unstructured":"Cisse M, Diallo AH, Som\u00e9 DA, Poda A, Awandare AG, Guiguemd\u00e9 TR. Association of placental Plasmodium falciparum parasitaemia with maternal and newborn outcomes in the periurban area of Bobo-Dioulasso, Burkina Faso. Parasitol Open. 2016;2:e15.","journal-title":"Parasitol Open."},{"key":"1695_CR21","unstructured":"Jonathan V, Sunil P, Chris D, Grant D, Daniel K, Sam N, et al. Protocols for detecting mutations conferring resistance to the antifolate class of antimalarial drugs: DHFR Ile-51, Arg-59, Asn-108, Leu-164, and DHPS Gly-437, Glu-540: April, 2004. http:\/\/www.muucsf.org\/protocols\/pdf\/Molecular markers of antifolate resistance (dhfr, dhps).pdf. Accessed 25 Mar 2013."},{"key":"1695_CR22","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/tmi.12305","volume":"19","author":"C Geiger","year":"2014","unstructured":"Geiger C, Compaore G, Coulibaly B, Sie A, Dittmer M, Sanchez C, et al. Substantial increase in mutations in the genes pfdhfr and pfdhps puts sulphadoxine\u2013pyrimethamine-based intermittent preventive treatment for malaria at risk in Burkina Faso. Trop Med Int Health. 2014;19:690\u20137.","journal-title":"Trop Med Int Health."},{"key":"1695_CR23","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4269\/ajtmh.2007.76.608","volume":"76","author":"H Tinto","year":"2007","unstructured":"Tinto H, Ou\u00e9draogo JB, Zongo I, van Overmeir C, van Marck E, Guiguemd\u00e9 TR, et al. Sulfadoxine\u2013pyrimethamine efficacy and selection of Plasmodium falciparum DHFR mutations in Burkina Faso before its introduction as intermittent preventive treatment for pregnant women. Am J Trop Med Hyg. 2007;76:608\u201313.","journal-title":"Am J Trop Med Hyg"},{"key":"1695_CR24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1475-2875-7-95","volume":"7","author":"M Tipke","year":"2008","unstructured":"Tipke M, Diallo S, Coulibaly B, St\u00f6rzinger D, Hoppe-Tichy T, Sie A, et al. Substandard antimalarial drugs in Burkina Faso. Malar J. 2008;7:95.","journal-title":"Malar J."},{"key":"1695_CR25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1475-2875-10-196","volume":"10","author":"G Bertin","year":"2011","unstructured":"Bertin G, Briand V, Bonaventure D, Carrieu A, Massougbodji A, Cot M, et al. Molecular markers of resistance to sulphadoxine\u2013pyrimethamine during intermittent preventive treatment of pregnant women in Benin. Malar J. 2011;10:196.","journal-title":"Malar J."},{"key":"1695_CR26","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1093\/jac\/dkv160","volume":"70","author":"P Chauvin","year":"2015","unstructured":"Chauvin P, Menard S, Iriart X, Nsango SE, Tchioffo MT, Abate L, et al. Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine\/pyrimethamine in pregnant women in Yaound\u00e9, Cameroon: emergence of highly resistant pfdhfr\/pfdhps alleles. J Antimicrob Chemother. 2015;70:2566\u201371.","journal-title":"J Antimicrob Chemother"},{"key":"1695_CR27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4269\/ajtmh.2007.76.237","volume":"76","author":"DA Diallo","year":"2007","unstructured":"Diallo DA, Sutherland C, Nebi\u00e9 I, Konat\u00e9 AT, Ord R, Pota H, et al. Sustained use of insecticide-treated curtains is not associated with greater circulation of drug-resistant malaria parasites, or with higher risk of treatment failure among children with uncomplicated malaria in Burkina Faso. Am J Trop Med Hyg. 2007;76:237\u201344.","journal-title":"Am J Trop Med Hyg"},{"key":"1695_CR28","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4269\/ajtmh.2006.75.162","volume":"75","author":"C Dokomajilar","year":"2006","unstructured":"Dokomajilar C, Lankoande ZM, Dorsey G, Zongo I, Ouedraogo J-B, Rosenthal PJ. Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine\u2013pyrimethamine in Burkina Faso. Am J Trop Med Hyg. 2006;75:162\u20135.","journal-title":"Am J Trop Med Hyg"},{"key":"1695_CR29","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1128\/AAC.01413-09","volume":"54","author":"AF Som\u00e9","year":"2010","unstructured":"Som\u00e9 AF, S\u00e9r\u00e9 YY, Dokomajilar C, Zongo I, Rouamba N, Greenhouse B, et al. Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether\u2013lumefantrine and amodiaquine-sulfadoxine\u2013pyrimethamine but not dihydroartemisinin\u2013piperaquine in Burkina Faso. Antimicrob Agents Chemother. 2010;54:1949\u201354.","journal-title":"Antimicrob Agents Chemother"},{"key":"1695_CR30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4269\/ajtmh.1999.60.475","volume":"60","author":"Y Diourt\u00e9","year":"1999","unstructured":"Diourt\u00e9 Y, Djimd\u00e9 A, Doumbo OK, Sagara I, Coulibaly Y, Dicko A, et al. Pyrimethamine-sulfadoxine efficacy and selection for mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase in Mali. Am J Trop Med Hyg. 1999;60:475\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"1695_CR31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.drup.2005.03.003","volume":"8","author":"I Hastings","year":"2005","unstructured":"Hastings I, Donnelly M. The impact of antimalarial drug resistance mutations on parasite fitness, and its implications for the evolution of resistance. Drug Resist Updat. 2005;8:43\u201350.","journal-title":"Drug Resist Updat."},{"key":"1695_CR32","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1475-2875-11-134","volume":"11","author":"NC Iriemenam","year":"2012","unstructured":"Iriemenam NC, Shah M, Gatei W, van Eijk AM, Ayisi J, Kariuki S, et al. Temporal trends of sulphadoxine\u2013pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya. Malar J. 2012;11:134.","journal-title":"Malar J."},{"key":"1695_CR33","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1128\/IAI.73.7.4190-4197.2005","volume":"73","author":"DO Ochiel","year":"2005","unstructured":"Ochiel DO, Awandare GA, Keller CC, Hittner JB, Kremsner PG, Weinberg JBPD. Differential regulation of beta-chemokines in children with Plasmodium falciparum malaria. Infect Immun. 2005;73:4190\u20137.","journal-title":"Infect Immun"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-017-1695-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T18:01:08Z","timestamp":1568743268000},"score":1,"resource":{"primary":{"URL":"http:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-017-1695-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,23]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1695"],"URL":"https:\/\/doi.org\/10.1186\/s12936-017-1695-1","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,23]]},"article-number":"38"}}